# BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update
Canonical URL: https://biopharmsignal.com/news/BCLI/brainstorm-cell-therapeutics-announces-first-quarter-2026-financial-results-and-provides-corporate-update
Ticker: BCLI
Company: Brainstorm Cell Therapeutics Inc.
Source: Brainstorm Cell Therapeutics Inc.
Published: 2026-05-15 20:05 EST
Original Source URL: https://ir.brainstorm-cell.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-06-02 13:00 EST — [BrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine](https://biopharmsignal.com/news/BCLI/brainstorm-cell-therapeutics-announces-publication-calling-for-updated-fda-approaches-to-als-rare-diseases-and-regenerative-medicine) — Source: Brainstorm Cell Therapeutics Inc.
- 2026-05-28 11:45 EST — [BrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors](https://biopharmsignal.com/news/BCLI/brainstorm-cell-therapeutics-appoints-former-fda-associate-commissioner-peter-j-pitts-to-board-of-directors) — Source: Brainstorm Cell Therapeutics Inc.
- 2026-05-19 12:00 EST — [BrainStorm Cell Therapeutics Announces Aggregate of $400,000 in Private Placements Priced at Premium to Market](https://biopharmsignal.com/news/BCLI/brainstorm-cell-therapeutics-announces-aggregate-of-400-000-in-private-placements-priced-at-premium-to-market) — Source: Brainstorm Cell Therapeutics Inc.
- 2026-05-15 20:05 EST — [BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update](https://biopharmsignal.com/news/BCLI/brainstorm-cell-therapeutics-announces-first-quarter-2026-financial-results-and-provides-corporate-update) — Source: Brainstorm Cell Therapeutics Inc.
- 2026-03-31 20:01 EST — [BrainStorm Cell Therapeutics Announces Full Year 2025 Financial Results and Provides Corporate Update](https://biopharmsignal.com/news/BCLI/brainstorm-cell-therapeutics-announces-full-year-2025-financial-results-and-provides-corporate-update) — Source: Brainstorm Cell Therapeutics Inc.
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)